Reports

Reports on the FDA's planning, performance, budgeting, user fee programs, and other agency-wide programs

• FDA Innovation Initiative
  Redoubling the agency’s efforts to encourage innovations that will promote public health as well as strengthen the American economy.
• Strategic Priorities
  Responding to the Public Health Challenges of the 21st Century: FDA goals and priority areas, 2011 - 2015
  • Archived Strategic Planning Documents
• Budgets
  Annual and multi-year budgeting documents in support of the nationwide public health protection programs administered by FDA.

• Risk Communication Reports
  FDA's Strategic Plan for Risk Communication and the book "Communicating Risks and Benefits: An Evidence-Based User's Guide," a report from FDA's Advisory Committee for Risk Communication and consultants showing how to incorporate and build on risk communication-related research.

• User Fee Reports
  Performance and financial reports on implementation of user fee programs supporting the review of human and animal drugs, biologics, and medical devices

• Performance Reports
  Reports on the review process for combination products

• Performance Plans
  Performance measurement and reporting documents

• Economic Analyses
  Economic analyses of important proposed and final regulations issued by the Food and Drug Administration.